Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the fiscal year ending June 20, 2023. For the year, the company expects net sales of JPY 168,000 million, operating income of JPY 5,800 million, net income attributable to owners of parent of JPY 3,900 million and net income per share of JPY 256.87.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,630 JPY | 0.00% | -2.76% | +3.11% |
Apr. 30 | Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended April 2024 | CI |
Apr. 25 | Genky Drugstores Co., Ltd. Provides Dividend Guidance for the Fiscal Year 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.11% | 559M | |
-31.79% | 15.36B | |
-21.99% | 12.45B | |
-22.64% | 6.75B | |
+9.74% | 6.14B | |
-10.91% | 6.07B | |
+0.58% | 4.78B | |
+59.24% | 4.53B | |
-9.00% | 3.81B | |
-12.53% | 3.43B |
- Stock Market
- Equities
- 9267 Stock
- News Genky DrugStores Co., Ltd.
- Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023